phenylalanine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudelsky, GA; Shankaran, M; Yamamoto, BK | 1 |
| Commandeur, JN; de Graaf, C; Keizers, PH; Lussenburg, BM; Mentink, LM; Vermeulen, NP | 1 |
| Commandeur, JN; Damsten, MC; Maasdijk, DM; van Vugt-Lussenburg, BM; Vermeulen, NP | 1 |
3 other study(ies) available for phenylalanine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum.
Topics: Animals; Corpus Striatum; Hydroxybenzoates; Hydroxyl Radical; Kinetics; Male; Mazindol; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Phenylalanine; Rats; Rats, Sprague-Dawley; Salicylic Acid; Serotonin; Tyrosine | 1999 |
Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)-coumarin metabolism.
Topics: Alanine; Coumarins; Cytochrome P-450 CYP2D6; Dextromethorphan; Humans; Models, Biological; Models, Molecular; Mutagenesis; N-Methyl-3,4-methylenedioxyamphetamine; Phenylalanine | 2004 |
Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3.
Topics: Acetaminophen; Amodiaquine; Arginine; Benzoflavones; Caffeine; Cytochrome P-450 Enzyme System; Dextromethorphan; Enzyme Activation; Humans; Kinetics; Leucine; Molecular Structure; Mutation; N-Methyl-3,4-methylenedioxyamphetamine; Pharmaceutical Preparations; Phenylalanine; Substrate Specificity | 2006 |